26 June 2019 - Kiwis diagnosed with the country's most common form of blood cancer are being put at unnecessary risk because they are not getting access to the best treatment options available, a support group warns.

Myeloma New Zealand chief executive Dr Ken Romeril, prompted by a new report released today looking at the burden of myeloma on society, says more needs to be done to ensure the 2,500 Kiwis living with myeloma have the same access to new life-changing myeloma treatments already available in other countries.

About 400 people are diagnosed with myeloma, a blood cancer affecting plasma cells typically found in bone marrow, and 180 people die from it each year. Symptoms include bone pain, bone fractures, anaemia, kidney damage and an increase in infections such as bacterial pneumonia and shingles.

Read New Zealand Herald article